SynBioBeta Speaker

James Joaquin

Obvious Ventures

Co-founder & Mng Director

James invests early in breakthrough technologies that move humanity forward. He’s passionate about the responsible use of AI to solve the unsolvable across trillion-dollar industries.



As a co-founder at Obvious, he has led investments for the firm that span advanced materials (Diamond Foundry), plant-based protein (Beyond Meat), and labor marketplaces (Incredible Health).

As an experienced startup operator, James served as President and CEO of Xoom.com (IPO). He was previously President and CEO of Ofoto from its early beginnings through acquisition by Kodak, leading its growth into the world’s largest online photo service. James also co-founded When.com, an Internet calendar and events service (acquired by AOL). He began his entrepreneurial career while studying computer science at Brown University, co-founding Clearview Software which was acquired by Apple, where he spent six years in engineering and marketing roles.

James grew up in a Portuguese fishing community in southeastern Massachusetts. He is a drummer, sailor, puzzler, and master of puns.

Sessions Featuring

James

This Year

Special Event

•

12:00 PM

-

1:15 PM

AIxBIO

AI + Biopharma Luncheon

The AI + Biopharma Luncheon at SynBioBeta 2026 brings together innovators working at the intersection of artificial intelligence and life sciences. This gathering offers a chance for founders, researchers, investors, and industry leaders to connect over lunch while exploring how AI is accelerating drug discovery, transforming R&D workflows, and reshaping the future of biopharma. The luncheon will also feature a panel discussion with Vivek Ardash, CEO of Mithrl, and Eric Kauderer-Abrams, Life Sciences at Anthropic, offering perspectives on how frontier AI models, scientific reasoning systems, and new computational tools are beginning to change the way biopharma teams generate insights, design experiments, and move from discovery to development.

Featuring

Eric Kauderer-Abrams

Anthropic

Head of Biology & Life Sciences

Vivek Adarsh

Mithrl

CEO & Co-Founder

James Joaquin

Obvious Ventures

Co-founder & Mng Director

Special Event

•

12:00 PM

-

1:15 PM

AIxBIO

AI + Biopharma Luncheon

The AI + Biopharma Luncheon at SynBioBeta 2026 brings together innovators working at the intersection of artificial intelligence and life sciences. This gathering offers a chance for founders, researchers, investors, and industry leaders to connect over lunch while exploring how AI is accelerating drug discovery, transforming R&D workflows, and reshaping the future of biopharma. The luncheon will also feature a panel discussion with Vivek Ardash, CEO of Mithrl, and Eric Kauderer-Abrams, Life Sciences at Anthropic, offering perspectives on how frontier AI models, scientific reasoning systems, and new computational tools are beginning to change the way biopharma teams generate insights, design experiments, and move from discovery to development.

Featuring

Eric Kauderer-Abrams

Anthropic

Head of Biology & Life Sciences

Vivek Adarsh

Mithrl

CEO & Co-Founder

James Joaquin

Obvious Ventures

Co-founder & Mng Director

Previous Speakers Include